← Back to all trials
Recruiting
NCT07473843
Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
Conditions: Homozygous Familial Hypercholesterolemia
Sex: All
Ages: 12 Years – 17 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 10
Sponsor: Arrowhead Pharmaceuticals
Location: Research Site St Louis Missouri
Summary
This study will evaluate the efficacy and safety of zodasiran subcutaneous (sc) injection in participants 12 to \
Eligibility Criteria
Inclusion Criteria:
* Adolescents 12 to \
Source: ClinicalTrials.gov (NCT07473843). StuddyBuddy aggregates publicly available trial information.